Better referral management can help to reduce low-value care, provide more coordinated care and allow a health system to retain more patients. Many providers currently recommend but fail to manage specialty, ancillary or pharmaceutical services following an initial visit. As a result, a surprisingly high percentage of patients may fail to get needed diagnostic, medical or specialty care that would help them stay healthy.
Alternatively, they may go to a high-cost provider or seek costly out-of-network care that may have positive outcomes but at a prohibitive cost. The health system ends up losing control, the patient loses out on appropriate care, and the payer ends up overpaying. It’s a losing proposition for all of the participants in this story.
To promote VBID, Philips Wellcentive has added cutting-edge referral management technology to our growing set of value-based care solutions. We recently partnered with Fibroblast to help health systems ensure that each patient is matched with the most appropriate doctor or service while saving money by minimizing out-of-network referrals.
Fibroblast’s HIPAA-compliant, proprietary web-based technology allows clinicians to focus on delivering high-value care while streamlining the referral process to improve care efficiencies for ACOs and other provider groups. In addition, narrowing the referral network can have care and cost improvements.